1,962,523 The Chemours Company $CC Shares Acquired by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. boosted its position in The Chemours Company (NYSE:CC) by 251.8% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 2,742,068 shares of the specialty chemicals company’s stock after purchasing an additional 1,962,523 shares during the period. Jefferies Financial Group Inc.’s holdings in Chemours were worth $37,210,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in CC. Parallel Advisors LLC grew its stake in shares of Chemours by 15.1% during the 3rd quarter. Parallel Advisors LLC now owns 5,926 shares of the specialty chemicals company’s stock worth $80,000 after acquiring an additional 776 shares during the period. Pekin Hardy Strauss Inc. raised its stake in Chemours by 150.6% in the 3rd quarter. Pekin Hardy Strauss Inc. now owns 201,082 shares of the specialty chemicals company’s stock valued at $2,729,000 after acquiring an additional 120,832 shares during the period. Chicago Partners Investment Group LLC bought a new stake in Chemours in the 3rd quarter valued at about $443,000. VIRGINIA RETIREMENT SYSTEMS ET Al raised its stake in Chemours by 853.8% in the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 99,200 shares of the specialty chemicals company’s stock valued at $1,346,000 after acquiring an additional 88,800 shares during the period. Finally, Sterling Capital Management LLC lifted its holdings in Chemours by 839.3% during the third quarter. Sterling Capital Management LLC now owns 5,072 shares of the specialty chemicals company’s stock valued at $69,000 after purchasing an additional 4,532 shares during the last quarter. 76.26% of the stock is currently owned by institutional investors.

Trending Headlines about Chemours

Investors following CC have been watching these headlines:

• Neutral Sentiment: Investors bought 21,465 Chemours call options on Wednesday, about 633% above the average volume of 2,930. This indicates unusually active options trading, but does not establish a clear direction for the stock. No article link was provided.
• Negative Sentiment: Multiple law firms reminded investors that December 7, 2026 is the deadline to seek lead-plaintiff status in a securities class action covering purchases from February 20 to August 4, 2026. The complaint alleges Chemours misrepresented demand for its Opteon refrigerants, including that strong 2025 sales masked an overfilled distribution channel and weaker underlying demand. These are allegations, not proven findings; the litigation could add uncertainty and potential costs. Article: CC Shareholder Alert
• Negative Sentiment: JPMorgan issued a pessimistic forecast for Chemours shares, adding to bearish sentiment. The supplied article information does not specify its price target or rationale. Article: JPMorgan Chase Issues Pessimistic Forecast for Chemours

Wall Street Analyst Weigh In

CC has been the subject of a number of research reports. Barclays initiated coverage on shares of Chemours in a research report on Monday, October 12th. They set an “equal weight” rating and a $16.00 target price for the company. The Goldman Sachs Group reiterated a “neutral” rating and issued a $16.00 target price on shares of Chemours in a research note on Friday, October 9th. Royal Bank Of Canada lowered shares of Chemours from an “outperform” rating to a “sector perform” rating and set a $14.00 price target on the stock. in a research report on Tuesday, October 13th. Zacks Research cut shares of Chemours from a “hold” rating to a “strong sell” rating in a research note on Wednesday, November 4th. Finally, Mizuho cut shares of Chemours from an “outperform” rating to a “neutral” rating and dropped their price target for the company from $18.00 to $15.00 in a research note on Wednesday, October 14th. Three analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, Chemours currently has a consensus rating of “Hold” and an average price target of $17.36.

Chemours Price Performance

Chemours stock opened at $13.73 on Thursday. The Chemours Company has a one year low of $10.44 and a one year high of $28.67. The business has a fifty day moving average price of $13.84 and a 200-day moving average price of $18.18. The company has a debt-to-equity ratio of 24.25, a current ratio of 1.81 and a quick ratio of 0.98. The firm has a market capitalization of $2.07 billion, a P/E ratio of -13.47 and a beta of 1.47.

Chemours (NYSE:CC) last announced its quarterly earnings results on Monday, November 2nd. The specialty chemicals company reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.26 by ($0.05). Chemours had a negative net margin of 2.64% and a positive return on equity of 76.52%. The company had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter last year, the firm posted $0.40 earnings per share. Chemours’s revenue for the quarter was up 3.0% compared to the same quarter last year. As a group, equities research analysts forecast that The Chemours Company will post 0.82 EPS for the current year.

Chemours Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, November 16th will be paid a $0.0875 dividend. The ex-dividend date is Monday, November 16th. This represents a $0.35 annualized dividend and a yield of 2.5%. Chemours’s dividend payout ratio (DPR) is currently -34.31%.

Chemours Profile

The Chemours Company is a global chemicals manufacturer spun off from DuPont in 2015 and headquartered in Wilmington, Delaware. It develops and produces materials used in industries ranging from construction and transportation to electronics and energy. Chemours’ Titanium Technologies business makes titanium dioxide (TiO₂) pigment, sold under the Ti-Pure brand, which is used to add whiteness, brightness and opacity to products such as paints, coatings, plastics and paper. Its Thermal & Specialized Solutions business supplies refrigerants, foam-blowing agents and other specialty fluids, including products marketed under the Opteon and Freon brands.